"By June 7th, all patients in the SPRING trial will have received the three follow-up phone calls and the six (6) week exam that followed the baseline exam at time of dosing. Clinical results from the completed trial, which includes additional follow-up calls and a final exam, will be made available in the third quarter of 2013. These results will be the basis for corporate strategy and business negotiations going forward."
"By June 7th, all patients in the SPRING trial will have received the three follow-up phone calls and the six (6) week exam that followed the baseline exam at time of dosing." Does it seem odd only to me that over two months later we haven't heard a peep from the company or even a leak on how goes it from the company. the gov't can't even keep a secret like that. If its good news. Why would they wait till the end of the third quarter to release it. Or am I missing something obvious here???
No because the company collating the data needs to put everything together and submit the data BEFORE any public announcement is made. AMPE did also announce they would report on this in August not July.
The company has publicly announced that they will share the results in August. Take a look at their UBS presentation, it will shed some light on the timeframes. This is still July!!! If you are that impatient, I'm sure there'a sell button that you can push and do us all a favor.
...should be any week now in August. If results mirror the Phase 1 Australian trial(or hopefully better as that trial was so limited), then Ampion will be THE drug of choice for OA, and a potential blockbuster in eventual sales.